Tirzepatide multi-dose pen, 3 mL, with green cap, dial showing 20 and white label

NovaPep

Buy Tirzepatide Pen Australia: Tirzepatide 3 mL Research Pen

$149AUD, GST included

In stock in Australia, batch certificate ready

Size: Pen, 3 mL

Certificate of analysis published for every batch
Third-party HPLC purity and MS identity testing
Dispatched same day before 3pm cut-off, tracked Australia-wide
Research use only, sold to adults aged 18 and over

Buy the Tirzepatide Pen online in Australia as a 3 mL multi-dose research cartridge, tested for identity and purity on every lot. The Tirzepatide Pen, stocked across Australia for laboratory research, is a 3 mL multi-dose cartridge holding tirzepatide (LY3298176) already in solution, a 39 amino acid peptide that activates both the GIP and GLP-1 receptors. The peptide carries a C20 fatty diacid that binds albumin, and the ready solution suits repeated bench sessions that must start from the same strength. Its reference identity is C225H348N48O68, 4813.5 g/mol and CAS 2023788-19-2. It ships from local stock and sits alongside the rest of our peptide pens in Australia. Mass spectrometry checks identity and HPLC checks purity on every cartridge lot before release, and the certificate of analysis is published online. As the solution is ready to use, there is no reconstitution and no bacteriostatic water involved. The Retatrutide Pen offers a matching triple agonist format, and the 2 mg tirzepatide vial lets you set your own concentration. Keep tirzepatide pens refrigerated at 2 to 8 °C in their carton and do not allow them to freeze. This research reagent is not the registered pharmacy pen, and NovaPep sells it to adults 18 and older for laboratory use only.

For laboratory research use only. Not for human or veterinary use. Not TGA approved. See the NovaPep research use policy.

What Is the Tirzepatide Pen?

A tirzepatide pen is a sealed cartridge of tirzepatide that has been dissolved in advance and filled at a fixed strength, held inside a pen-shaped body that protects the solution until use. The molecule is exactly the same as the dry powder, and details of the compound itself, including its two receptors, how it was developed and its trial history, are on the tirzepatide vial page. This page focuses on the format. The Tirzepatide Pen is for sale in Australia as a 3 mL research cartridge, ready to order online from local stock.

Our pen has a green cap, a dose dial and a white label, and holds a sealed 3 mL cartridge of tirzepatide solution that should appear clear through the window. Each lot has its fill strength printed on the label. The cartridge contains the same LY3298176 sequence as our dry vial, with only the presentation changed, so the pen and powder can serve as matched arms within one study.

Inside the Cartridge: How Tirzepatide Works

The cartridge contains the identical 39-residue chain, a GIP-based sequence with Aib substitutions that protect against DPP-4, an amidated C-terminus and a C20 fatty diacid attached to lysine 20 for albumin binding. Since it is already in solution, the pen is tested in that form, with mass spectrometry matching the peptide to its expected mass of about 4813.5 g/mol and HPLC giving the purity for the lot.

How the Pre-Filled Format Works

A pre-filled pen flips the normal bench routine around. Rather than a lab weighing out powder and dissolving it, the peptide is put into a liquid vehicle during manufacture, run through a sterilising filter, filled into the cartridge and sealed. The completed lot is then tested in solution form. This order helps with record keeping, because the certificate reports precisely what the cartridge contains, rather than describing a powder that will later be mixed with an unrecorded volume of diluent. For teams that must document the source of every working concentration, one fixed starting strength makes the audit trail much simpler.

Tirzepatide Pen Research: What Bench Studies Need to Control

This is the same dual agonist we sell as a dry vial, with the weighing, the diluent and the concentration maths already taken care of. Eli Lilly developed tirzepatide as the first single peptide to act on both the GIP and GLP-1 receptors, and it is still the usual comparator in incretin research. A ready solution fits groups that run one assay many times and want to eliminate a source of variation between sessions. Shop the Tirzepatide Pen online in Australia for this research, knowing each lot has been checked for identity and purity.

Its C20 fatty acid chain makes tirzepatide partly lipophilic, and that becomes noticeable once the peptide is diluted out of a pen. Acylated peptides generally stick to plastic, so at low nanomolar concentrations a meaningful fraction may be lost to the walls of ordinary tubes and plates before reaching the cells. That same fatty acid also binds albumin. In serum-containing culture medium, some of the tirzepatide is therefore bound to albumin instead of being free to reach the receptor, which shifts apparent potency to the right relative to serum-free conditions.

Both points lead to the same advice. Prepare serial dilutions from the cartridge in low-binding tubes. Where you need a carrier protein to prevent loss to plastic, use something other than albumin, such as casein, because albumin would capture the very chain you want to keep free. Also record the serum or albumin content of your assay medium in your methods, since two labs using the same pen in different media can report conflicting potencies for that reason alone. A cartridge gives you consistency at the beginning of an experiment, but it cannot rescue a peptide that is diluted carelessly later on.

Tirzepatide Pen Specifications

Product name	Tirzepatide Pen (tirzepatide, LY3298176)
Size	Pen with 3 mL cartridge
Structure	Peptide agonist of both the GIP and GLP-1 receptors, carrying a C20 fatty diacid side chain, supplied as a solution
Peptide length	39 amino acids
Formula	C225H348N48O68
Molar mass	4813.5 g/mol
CAS	2023788-19-2
Presentation	Ready solution in a 3 mL multi-dose pen cartridge, pre-filled
Quality testing	Identity by mass spectrometry and purity by HPLC, with a certificate of analysis for each cartridge lot
In the box	A single pre-filled pen containing a 3 mL cartridge, with no diluent needed
Storage conditions	2 to 8 °C inside the carton, protected from light and never allowed to freeze
Stock status	In stock
Intended use	In vitro laboratory research only

Choose the pen when each session needs to begin with exactly the same solution and you want to remove the preparation step from your routine. Every cartridge lot is tested ahead of release and the report is published online, so the contents are known before the pen is even packed.

Use the lot code on the pen label to open the corresponding report in our COA library. Check that the name, measured mass and lot code all match the pen you are holding before you put it in the fridge.

Handling and Storage of the Tirzepatide Pen

Place the pen in the fridge at 2 to 8 °C on the day it is delivered, keeping it in its carton and out of the light. Do not freeze it, and throw away any pen whose contents have frozen. Before every session, check through the window that the liquid is clear with no particles. The Tirzepatide Pen for sale in Australia leaves our shelves by tracked post, so it reaches your bench in good condition.

You do not need to reconstitute anything. If your study also includes a vial arm, adding 1 mL of bacteriostatic water to the 2 mg vial produces 2 mg/mL, and the reconstitution calculator works out any other volume so both arms line up on paper.

The Tirzepatide Pen Compared With the Vial and the Retatrutide Pen

Choose the pen for speed and consistency between sessions, and the vial for a custom concentration or longer storage. Looking across compounds, the Retatrutide Pen comes in the same 3 mL cartridge format with a triple agonist that also targets the glucagon receptor. The two pens make a natural pair and the difference between them isolates that third pathway.

One practical factor settles many orders. A dry vial can stay in a freezer for months, whereas a solution in a cartridge has a shorter life and should be used within the period stated on its label. Pens suit sessions already scheduled, and vials suit stock you intend to hold. Teams that run both often use the pen for day-to-day work and keep one vial from a matching lot frozen in reserve.

Other Names for the Tirzepatide Pen

Some suppliers describe this format as a tirzepatide pen injector, a pre-filled tirzepatide pen, a multi-dose cartridge or just a tirz pen. The active compound may be listed as tirzepatide or LY3298176, and CAS 2023788-19-2 is the fixed identifier for both.

Mounjaro is the brand registered in Australia, and Zepbound is a brand used in the US. Neither describes this research product. On the receptor side, GIP stands for glucose-dependent insulinotropic polypeptide and GLP-1 for glucagon-like peptide-1.

Buy the Tirzepatide Pen Online in Australia

There is one size to buy, a 3 mL cartridge sealed in the pen body. Its strength is set at filling and printed on the label, so compare it with your protocol before ordering. A pen cannot be changed to a different concentration without decanting the solution, which would undo the whole point of the format.

For a study needing several pens, order them from one lot where stock permits, and a single certificate will cover the entire series. Checkout is limited to adults aged 18 and over, who confirm their age before paying. If flexibility is more important than speed, the lyophilised tirzepatide vial lets you choose your concentration and stays stable far longer as a dry powder.

We trade online only, from stock held in Australia, so identical pens go to Darwin, regional towns and every lab buying peptides in Hobart. If you pay before 3pm on a business day, the pen is packed and shipped that afternoon. Our delivery information page describes the services, and the order tracking page shows the parcel's progress to your door.

The Research Pen Versus the Mounjaro KwikPen

The term "tirzepatide pen" also refers to a registered medicine, and the two are often confused. Since September 2024, Australian pharmacies have dispensed the Mounjaro KwikPen, Lilly's multi-dose pre-filled pen. According to the TGA, its dose strengths match those of the earlier Mounjaro vials, and its approved uses cover type 2 diabetes and chronic weight management. It can only be supplied on prescription, and as of October 2026 it remains unsubsidised on the PBS after Lilly pulled out of the listing process in 2026.

Lilly does not make our pen. It has no ARTG listing, it is not a KwikPen and no prescription can be filled with it. Its only purpose is to give benches a ready solution of a well-characterised dual agonist without having to weigh powder. NovaPep keeps it in Australian stock as a laboratory reagent, sells it solely to adults 18 and over, and does not supply it for human or veterinary use. If you are choosing between a tirzepatide pen and a triple agonist in the same format, our retatrutide and tirzepatide comparison explains the receptor differences, and the wider metabolic research range lists every incretin and amylin compound we carry.

It is not the registered tirzepatide pen that Australian pharmacies dispense on prescription. It is a research-grade laboratory reagent without any therapeutic approval, sold to adults for bench work and never for use in humans or animals. You will find other incretin and amylin compounds in our metabolic peptides range.

Tirzepatide Pen at a Glance

Tirzepatide ready in solution

A pre-filled 3 mL cartridge containing the dual GIP and GLP-1 agonist, so there is nothing to weigh, mix or calculate.

Order the pen

A single pen with its strength printed on the label. This format does not need bacteriostatic water.

For bench research only

Suited to repeated receptor and cell assays that call for the same starting solution each time. It is not the pharmacy pen and is never for human use.

Pairs with the Retatrutide Pen

The same cartridge format, with one receptor fewer. Comparing both pens isolates the glucagon pathway.

Keep it refrigerated

Store at 2 to 8 °C in the carton from the day it arrives. Do not freeze, and confirm the solution is clear before each session.

Tested by cartridge lot

Mass spectrometry confirms identity and HPLC measures purity for every cartridge lot, and the report is published online.

Tirzepatide Pen FAQ

What is the Tirzepatide Pen and how does tirzepatide work?

The pen is a sealed 3 mL cartridge of tirzepatide pre-dissolved at a fixed strength. Tirzepatide is a 39 residue peptide that activates both the GIP and GLP-1 receptors. Aib substitutions protect it from DPP-4, and a C20 fatty diacid on lysine 20 binds albumin.

Is this Tirzepatide Pen the pharmacy product?

No. Registered tirzepatide pens are prescription medicines supplied by Australian pharmacies. This pen is a research-grade reagent sold to adults for laboratory work only. It has no therapeutic approval, it cannot substitute for the prescription product and it must never be used in people or animals.

What is the right way to store a Tirzepatide Pen after delivery in Australia?

Put it in a fridge at 2 to 8 °C on the day it arrives and keep it in its carton, protected from light. If a pen has frozen, discard it instead of using it. Before each session, hold the window up to the light and confirm the solution is clear.

Which should I buy, the pre-filled tirzepatide pen or the 2 mg vial?

Buy the pen if you run the same procedure many times and need each session to begin with an identical solution. Buy the 2 mg tirzepatide vial if you want to set your own concentration, need a small comparator amount or want stock that lasts longer as dry powder in the freezer.

What is the process to buy a Tirzepatide Pen online in Australia?

Put the pen in your cart from this page, and it will ship from our Australian stock. If you pay before 3pm on a weekday it goes out that afternoon, tracked to your address. The solution comes ready to use, so you need no diluent or reconstitution supplies, and you can review the lot certificate beforehand.

Is a certificate of analysis supplied with the Tirzepatide Pen?

Yes. Every cartridge lot is tested in solution, with mass spectrometry confirming tirzepatide and HPLC measuring purity. You will find the certificate in our COA library under the lot code shown on the pen label, ready to download and file with your records.